Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Human Cervical Mucus Plug… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Human Cervical Mucus Plugs Exhibit Insufficiencies in Antimicrobial Activity Towards Group B Streptococcus

Artikel i vetenskaplig tidskrift
Författare J. Vornhagen
P. Quach
V. Santana-Ufret
V. Alishetti
A. Brokaw
B. Armistead
H. Q. Tang
J. W. MacDonald
T. K. Bammler
Kristina M. Adams Waldorf
N. Uldbjerg
L. Rajagopal
Publicerad i Journal of Infectious Diseases
Volym 217
Nummer/häfte 10
Sidor 1626-1636
ISSN 0022-1899
Publiceringsår 2018
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi
Sidor 1626-1636
Språk en
Länkar https://doi.org/10.1093/infdis/jiy0...
Ämnesord cervical mucus plugs, antimicrobial peptide, group B streptococcus, growth inhibition, pregnancy, capsular polysaccharide, amniotic cavity, s100 proteins, l-ficolin, infection, preterm, pregnancy, virulence, complement, mechanisms, Immunology, Infectious Diseases, Microbiology
Ämneskategorier Mikrobiologi inom det medicinska området, Infektionsmedicin, Immunologi

Sammanfattning

Preterm birth is a leading cause of neonatal mortality and lacks an effective therapy. Ascending microbial infections from the lower genital tract lead to infection of the placenta, amniotic fluid, and fetus causing preterm birth or stillbirth. Directly in the path of an ascending infection is the cervical mucus plug (CMP), a dense mucoid structure in the cervical canal with potential antimicrobial properties. In this study, we aimed to define the components of CMP responsible for antimicrobial activity against a common lower genital tract organism associated with preterm birth and stillbirths, namely, group B streptococcus (GBS). Using a quantitative proteomic approach, we identified antimicrobial factors in CMPs that were collected from healthy human pregnancies. However, we noted that the concentration of antimicrobial peptides present in the human CMPs were insufficient to directly kill GBS, and antimicrobial activity, when observed, was due to antibiotics retained in the CMPs. Despite this insufficiency, CMP proteins were able to activate leukocytes in whole blood resulting in increased rates of bacterial killing, suggesting a role for the CMP in enhancing complement-mediated killing or leukocyte activation. This study provides new insight into how the human CMP may limit ascending bacterial infection.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?